Report #2837671

Overview

Sex

Male

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

They administered Boostrix, the patient was supposed to get a ppd instead; Patient received Boostrix in the left lower fore arm intradermal; This non-serious case was reported by a consumer via call center representative and described the occurrence of wrong product administered in a 22-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 333SK, expiry date 28-SEP-2025) for prophylaxis. Co-suspect products included tuberculin ppd (Ppd Disposable) for product used for unknown indication. On an unknown date, the patient received Boostrix (intradermal, left lower forearm) and did not receive Ppd Disposable. On an unknown date, an unknown time after receiving Boostrix, the patient experienced wrong product administered (Verbatim: They administered Boostrix, the patient was supposed to get a ppd instead) and intramuscular formulation administered by other route (Verbatim: Patient received Boostrix in the left lower fore arm intradermal). The action taken with Ppd Disposable was unknown. The outcome of the wrong product administered and intramuscular formulation administered by other route were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-APR-2025 On 14 April 2025 an office manager called to report that they administer Boostrix in error and in a wrong area to a 22 years old male patient. They administered Boostrix in the left lower fore arm intradermal. The patient was supposed to get a ppd instead which led to wrong product administered and intramuscular formulation administered by other route. The reporter wanted to know if there are any possible side effects to consider. Consented to follow up.